Epsilon Healthcare Limited
Epsilon Healthcare Limited
- Market cap
- $544.75K
- P/E ratio
- 83.33
Your view on HDRPF
Overview
What the company does, where it operates, and who runs it.
About Epsilon Healthcare Limited
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Peter Giannopoulos
- Headquarters
- 9 Castlereagh Street, Sydney, NSW, AU
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Peter Giannopoulos
- Headquarters
- 9 Castlereagh Street, Sydney, NSW, AU
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. It engages in the manufacture and distribution of hydroponics equipment, materials, and nutrients; and development and delivery of medicinal cannabis, as well as provides turnkey cannabis cultivation solutions.
The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Epsilon Healthcare Limited. Starting points for Epsilon Healthcare Limited: P/E 83.3, beta 0.71 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Epsilon Healthcare Limited. Epsilon Healthcare Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Epsilon Healthcare Limited. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Epsilon Healthcare Limited. Epsilon Healthcare Limited has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CL.CNCresco Labs Inc. | Healthcare | CNQ | $565.2M | ||
| CLC.CNChristina Lake Cannabis Corp. | Healthcare | CNQ | $9.9M | ||
| CLCFFChristina Lake Cannabis Corp. | Healthcare | OTC | $6.2M | ||
| CLVRClever Leaves Holdings Inc. | Healthcare | OTC | $702 | ||
| CNFHFCanaFarma Hemp Products Corp. | Healthcare | OTC | $19,561 | ||
| CNGGFCann Group Limited | Healthcare | OTC | $4.4M | ||
| CNNACann American Corp. | Healthcare | OTC | $1.1M | ||
| CNNCCannonau Corp. | Healthcare | OTC | $72,413 | ||
| CNTMFFluent Corp. | Healthcare | OTC | $18.3M | ||
| COLLCollegium Pharmaceutical, Inc. | Healthcare | NASDAQ | $805.8M | ||
| CPH.TOCipher Pharmaceuticals Inc. | Healthcare | TSX | $331.7M | ||
| CPHIChina Pharma Holdings, Inc. | Healthcare | AMEX | $22.0M | ||
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Epsilon Healthcare Limited, and how their positions are changing. At a $544,746 market value, institutional positions materially move Epsilon Healthcare Limited's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Epsilon Healthcare Limited executives and directors. Shares of Epsilon Healthcare Limited have traded between $0.0014 and $0.0014 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Epsilon Healthcare Limited. Epsilon Healthcare Limited is a $544,746 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Epsilon Healthcare Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Epsilon Healthcare Limited. Coverage tracks Epsilon Healthcare Limited within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Epsilon Healthcare Limited.